Literature DB >> 2262559

Immunohistochemical demonstration of pancreatic secretory trypsin inhibitor in normal and neoplastic colonic mucosa.

H Bohe1, M Bohe, C Lindström, K Ohlsson.   

Abstract

Specimens of normal and neoplastic colonic mucosa from 52 patients were analysed by immunohistochemistry using a monospecific polyclonal antiserum against human pancreatic secretory trypsin inhibitor (PSTI). In normal colonic mucosa PSTI was found in the goblet cells in the basal parts of the crypts. In adenomas of tubular, villous, and tubulo-villous types PSTI was also found in the upper parts of the polyps, usually occurring in the regeneration zone. There was a more intense staining reaction in polyps with increased atypia. Carcinomas of different types and of various grades of differentiation and of in situ type did not contain PSTI. These findings indicate that PSTI could be a marker for adenomatous rather than carcinomatous epithelium in the colon. Furthermore, the absence of the inhibitor in malignant cells might facilitate tissue invasion by malignant cells because of deficient protease inhibition.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2262559      PMCID: PMC502898          DOI: 10.1136/jcp.43.11.901

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  11 in total

1.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

Review 2.  The role of proteinases in cellular invasiveness.

Authors:  D E Mullins; S T Rohrlich
Journal:  Biochim Biophys Acta       Date:  1983-12-29

3.  Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases.

Authors:  K Matsuda; M Ogawa; A Murata; T Kitahara; G Kosaki
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1983-05

4.  Distribution of antileukoprotease in upper respiratory mucosa.

Authors:  U Fryksmark; K Ohlsson; A Polling; H Tegner
Journal:  Ann Otol Rhinol Laryngol       Date:  1982 May-Jun       Impact factor: 1.547

5.  Purification and immunochemical quantitation of human pancreatic secretory trypsin inhibitor.

Authors:  A Eddeland; K Ohlsson
Journal:  Scand J Clin Lab Invest       Date:  1978-05       Impact factor: 1.713

6.  Pancreatic endoproteases and pancreatic secretory trypsin inhibitor immunoreactivity in human Paneth cells.

Authors:  M Bohe; A Borgström; C Lindström; K Ohlsson
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

7.  Immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal mucosa.

Authors:  M Bohe; C Lindström; K Ohlsson
Journal:  Adv Exp Med Biol       Date:  1988       Impact factor: 2.622

8.  Purification and characterization of pancreatic secretory trypsin inhibitor in human gastric mucosa.

Authors:  T Shibata; M Ogawa; K Matsuda; K Miyauchi; T Yamamoto; T Mori
Journal:  Clin Chim Acta       Date:  1986-08-30       Impact factor: 3.786

9.  Immunohistochemical localization of pancreatic secretory trypsin inhibitor in fetal and adult pancreatic and extrapancreatic tissues.

Authors:  M Fukayama; Y Hayashi; M Koike; M Ogawa; G Kosaki
Journal:  J Histochem Cytochem       Date:  1986-02       Impact factor: 2.479

10.  Immunoreactive pancreatic secretory trypsin inhibitor in sera from patients with acute ulcerative colitis.

Authors:  M Bohe
Journal:  Res Exp Med (Berl)       Date:  1987
View more
  7 in total

1.  Immunoreactive pancreatic secretory trypsin inhibitor in normal, inflammatory and neoplastic gallbladders.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1991-02

2.  Production and secretion of pancreatic secretory trypsin inhibitor in normal human small intestine.

Authors:  H Bohe; M Bohe; E Lundberg; A Polling; K Ohlsson
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

3.  Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker.

Authors:  Yi-Ting Chen; Shu-Chuan Tsao; Shyng-Shiou F Yuan; Hung-Pei Tsai; Chee-Yin Chai
Journal:  Pathol Oncol Res       Date:  2015-06-03       Impact factor: 3.201

4.  Localization of immunoreactive secretory leukocyte protease inhibitor (SLPI) in intestinal mucosa.

Authors:  M Bergenfeldt; M Nyström; M Bohe; C Lindström; A Polling; K Ohlsson
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

5.  Pancreatic secretory trypsin inhibitor in human Brunner's glands.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

6.  Quantification of pancreatic secretory trypsin inhibitor in colonic carcinoma and normal adjacent colonic mucosa.

Authors:  H Bohe; M Bohe; P Jönsson; C Lindström; K Ohlsson
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

7.  Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2.

Authors:  S K Bohm; W Kong; D Bromme; S P Smeekens; D C Anderson; A Connolly; M Kahn; N A Nelken; S R Coughlin; D G Payan; N W Bunnett
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.